Physician profile
John L Culleton
NPI 1619917309
$1,454.31
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $598 · 2021: $83.28 · 2022: $112.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $421.31 | 2020 | |
| Insulet Corporation | $181.61 | 2019-2022 | |
| Medtronic Minimed, INC. | $119.69 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $104.86 | 2019-2021 | |
| Mannkind Corporation | $100.79 | 2019-2020 | |
| Lilly USA, LLC | $72.04 | 2019-2022 | |
| Amgen INC. | $62.98 | 2019-2022 | |
| Novo Nordisk INC | $55.73 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $53.60 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $42.49 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $36.68 | 2019-2020 | |
| Corcept Therapeutics | $31.86 | 2021-2022 | |
| Shire North American Group INC | $28.91 | 2019 | |
| Amarin Pharma, INC. | $26.47 | 2019-2020 | |
| Becton, Dickinson and Company | $21.17 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $19.41 | 2022 | |
| Companion Medical, INC. | $17.41 | 2020 | |
| Valeritas, INC. | $15.89 | 2019 | |
| Abbvie INC. | $14.87 | 2019 | |
| Ibsa Pharma INC. | $14.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Culleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.